Live from the NIH registry
Studies recruiting near Lexington right now
Top 25 of 480 recruiting studies, sorted by proximity — each links to its official registry page
COMPASSION S3 - Evaluation of the SAPIEN 3 Transcatheter Heart Valve in Patients With Pulmonary Valve Dysfunction
Complex Congenital Heart Defect, Dysfunctional RVOT Conduit
N/A
Interventional 108 participants sought
University of Kentucky — Lexington, Kentucky (3.8 mi)
· Sponsor: Edwards Lifesciences
Registry of Participants With Generalized Myasthenia Gravis Treated With Alexion C5 Inhibition Therapies (C5ITs)
Generalized Myasthenia Gravis
N/A
Observational 500 participants sought
Clinical Trial Site — Lexington, Kentucky (3.8 mi)
· Sponsor: Alexion Pharmaceuticals, Inc.
Evaluation of a New Strategy for Protocolized Antibiotic Care for Severe Open Fractures: SEXTANT 2
Post Operative Surgical Site Infection
Phase 3
Interventional 600 participants sought
University of Kentucky — Lexington, Kentucky (3.8 mi)
· Sponsor: Major Extremity Trauma Research Consortium
A Study Assessing Corneal Endothelial Cells in Participants With Neovascular Age-related Macular Degeneration (nAMD) Treated With the Port Delivery System With Ranibizumab (PDS)
Neovascular Age-related Macular Degeneration
Phase 4
Interventional 188 participants sought
Retina Associates of Kentucky — Lexington, Kentucky (3.8 mi)
· Sponsor: Genentech, Inc.
Multisite Inventory of Neonatal-Perinatal Interventions (MINI) Minimum Dataset
Infant, Extremely Premature, Obstetric Labor, Premature
N/A
Observational 5,000 participants sought
Golisano Children's at the University of Kentucky — Lexington, Kentucky (3.8 mi)
· Sponsor: The University of Texas Health Science Center, Houston
A Study to Evaluate Avacopan in Participants With ANCA-associated Vasculitis
Antineutrophil Cytoplasmic Antibody-associated Vasculitis
Phase 4
Interventional 300 participants sought
University of Kentucky — Lexington, Kentucky (3.8 mi)
· Sponsor: Amgen
BMS-986489 (Atigotatug + Nivolumab) vs Durvalumab in Limited-stage Small-cell Lung Cancer (TIGOS-LS)
Limited Stage Small Cell Lung Cancer
Phase 2
Interventional 250 participants sought
Baptist Health - Lexington — Lexington, Kentucky (3.8 mi)
· Sponsor: SCRI Development Innovations, LLC
WRAP North America
Venous Stenosis, Venous Occlusion
N/A
Observational 250 participants sought
University of Kentucky — Lexington, Kentucky (3.8 mi)
· Sponsor: Merit Medical Systems, Inc.
A Phase II Nationwide, Fully Decentralized, Telemedicine Study of Pemigatinib in Adult Patients With Advanced or Metastatic Pancreatic Cancer With FGFR Genetic Alterations
Advanced Pancreatic Carcinoma, Metastatic Pancreatic Carcinoma
Phase 2
Interventional 40 participants sought
Ohio State University-Telemedicine — Lexington, Kentucky (3.8 mi)
· Sponsor: Sameek Roychowdhury
Methadone for Post-operative Spine Surgery
Pain, Postoperative
Phase 4
Interventional 30 participants sought
University of Kentucky — Lexington, Kentucky (3.8 mi)
· Sponsor: Brandon Knopp
A Study of MZE782 in Adults With PKU
Phenylketonuria (PKU)
Phase 2
Interventional 38 participants sought
University of Kentucky Medical Center — Lexington, Kentucky (3.8 mi)
· Sponsor: Maze Therapeutics
Reaching Rural Cancer Survivors Who Smoke Using Text-Based Program
Cigarette Smoking-Related Carcinoma
Phase 3
Interventional 600 participants sought
CommonSpirit Saint Joseph Hospital - Lexington — Lexington, Kentucky (3.8 mi)
· Sponsor: Alliance for Clinical Trials in Oncology
Comprehensive Connected Cancer Care (C4): Intervention Evaluation
Cancer, Health Care Utilization
N/A
Interventional 300 participants sought
University of Kentucky — Lexington, Kentucky (3.8 mi)
· Sponsor: Timothy Mullett
Testing Olaparib for One or Two Years, With or Without Bevacizumab, to Treat Ovarian Cancer
Fallopian Tube Endometrioid Adenocarcinoma, Fallopian Tube High Grade Serous Adenocarcinoma
Phase 3
Interventional 880 participants sought
Baptist Health Lexington — Lexington, Kentucky (3.8 mi)
· Sponsor: NRG Oncology
Narrow Excision Versus Wide Excision for the Treatment of Adults With Invasive Cutaneous Melanoma, ICEMAN Trial
Clinical Stage IA Cutaneous Melanoma AJCC v8, Clinical Stage IB Cutaneous Melanoma AJCC v8
N/A
Interventional 1,000 participants sought
University of Kentucky/Markey Cancer Center — Lexington, Kentucky (3.8 mi)
· Sponsor: OHSU Knight Cancer Institute
Artificial Intelligence Mapping and Ablation of Non-Pulmonary Vein Electrical Drivers of AF Study
Atrial Fibrillation (AF)
N/A
Interventional 423 participants sought
Baptist Health Lexignton — Lexington, Kentucky (3.8 mi)
· Sponsor: Vektor Medical
Evaluating Clinical Hiatal Hernia Outcomes Using OviTex®
Hiatal Hernia
N/A
Interventional 173 participants sought
University of Kentucky — Lexington, Kentucky (3.8 mi)
· Sponsor: Tela Bio Inc
Testing the Addition of an Anti-Cancer Drug, Camonsertib, to Radiation Therapy for Recurrent Head and Neck Squamous Cell Carcinoma
Multiple conditions
Phase 1
Interventional 39 participants sought
University of Kentucky/Markey Cancer Center — Lexington, Kentucky (3.8 mi)
· Sponsor: National Cancer Institute (NCI)
A Study to Assess Disease Activity and Adverse Events of Intravenous (IV) Telisotuzumab Vedotin Compared to IV Docetaxel in Adult Participants With Previously Treated Non-Squamous Non-Small Cell Lung Cancer (NSCLC)
Non Small Cell Lung Cancer, c-MET
Phase 3
Interventional 768 participants sought
Baptist Health Lexington /ID# 252769 — Lexington, Kentucky (3.8 mi)
· Sponsor: AbbVie
Parkinson's Foundation PD GENEration Genetic Registry
Parkinson's Disease
N/A
Observational 35,382 participants sought
University of Kentucky — Lexington, Kentucky (3.8 mi)
· Sponsor: Parkinson's Foundation
Evaluating Safety and Feasibility of Transcutaneous Spinal Cord Stimulation Following Traumatic and Non-Traumatic Spinal Cord Injury: A Pilot Study
Spinal Cord Stimulation, Electric Stimulation Therapy
N/A
Interventional 30 participants sought
University of Kentucky - Chandler Medical Center — Lexington, Kentucky (3.8 mi)
· Sponsor: Francis Farhadi
A Phase Ib Study of VK-2019 in Patients With Relapsed or Refractory EBV+ Diffuse Large B-cell Lymphomas (DLBCL)
Diffuse Large B Cell Lymphoma Refractory, Diffuse Large B Cell Lymphoma Relapsed
Phase 1
Interventional 30 participants sought
University of Kentucky — Lexington, Kentucky (3.8 mi)
· Sponsor: Pierluigi Porcu
A Study to Evaluate the Optimal Dose, Adverse Events and Change in Disease Activity of Intravenous ABBV-706 in Combination With Atezolizumab Versus Standard of Care as First-Line Treatment in Adult Participants With Previously Untreated Extensive Stage Small Cell Lung Cancer
Small Cell Lung Cancer
Phase 2
Interventional 180 participants sought
Baptist Health Lexington /ID# 277729 — Lexington, Kentucky (3.8 mi)
· Sponsor: AbbVie
Palatal Wound Healing After Free Gingival Graft Harvest in Diabetic Patients: A Clinical Trial
Diabetes Mellitus, Gingival Recession, Generalized
N/A
Interventional 40 participants sought
College of Dentistry - University of Kentucky — Lexington, Kentucky (3.8 mi)
· Sponsor: Mauro Santamaria
A Long-Term Safety Study of Elismetrep (K-304) in the Acute Treatment of Migraine
Acute Migraine
Phase 3
Interventional 1,000 participants sought
AMR Clinical - Lexington — Lexington, Kentucky (3.8 mi)
· Sponsor: TriGemX Bio, Inc.